相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Native T1 Mapping in Transthyretin Amyloidosis
Marianna Fontana et al.
JACC-CARDIOVASCULAR IMAGING (2014)
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy
Simone Longhi et al.
JACC-CARDIOVASCULAR IMAGING (2014)
Cardiac amyloidosis: Updates in diagnosis and management
Dania Mohty et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2013)
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective
Claudio Rapezzi et al.
EUROPEAN HEART JOURNAL (2013)
Markedly Increased Volume of Distribution of Gadolinium in Cardiac Amyloidosis Demonstrated by T1 Mapping
Jeremy Brooks et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
Native T1 Mapping in Differentiation of Normal Myocardium From Diffuse Disease in Hypertrophic and Dilated Cardiomyopathy
Valentina O. Puntmann et al.
JACC-CARDIOVASCULAR IMAGING (2013)
Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis
Theodoros D. Karamitsos et al.
JACC-CARDIOVASCULAR IMAGING (2013)
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
James C. Moon et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2013)
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS)
Frederick L. Ruberg et al.
AMERICAN HEART JOURNAL (2012)
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report
Arnt V. Kristen et al.
CLINICAL RESEARCH IN CARDIOLOGY (2012)
Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging
Steven K. White et al.
HEART (2012)
Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial
Teresa Coelho et al.
NEUROLOGY (2012)
Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: In Vivo Evidence from FAP Mice Models
Nelson Ferreira et al.
PLOS ONE (2012)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rate of Progression of Transthyretin Amyloidosis
Merrill D. Benson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis Preliminary Validation in Humans
Andrew S. Flett et al.
CIRCULATION (2010)
Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis
Derliz Mereles et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity
Nelson Ferreira et al.
FEBS LETTERS (2009)
Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy
Michael Jerosch-Herold et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Quantitative myocardial distribution volume from dynamic contrast-enhanced MRI
Nathan A. Pack et al.
MAGNETIC RESONANCE IMAGING (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis
Alicia M. Maceira et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2008)
Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro
Elizabeth Kehr et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2008)
Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option?
Werner Hunstein
BLOOD (2007)
Senile systemic amyloidosis presenting with heart failure - A comparison with light chain-associated amyloidosis
B Ng et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
分享论文
